{"count": 6, "results": [{"_id": "2550638", "pmid": 2550638, "title": "Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.", "journal": "J Hum Hypertens", "authors": ["Hayes PC", "Plevris JN", "Bouchier IA"], "date": "1989-06-01T00:00:00Z", "meta_date_publication": "1989 Jun", "meta_volume": "3 Suppl 1", "meta_issue": "", "meta_pages": "153-8", "score": 50067.848, "text_hl": "The pharmacokinetic and pharmacodynamic profiles of two angiotensin-converting enzyme (ACE) inhibitors, @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ (a prodrug) and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ (directly acting), were compared in eight @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@hepatic cirrhosis@@@ and 10 healthy controls. ", "citations": {"NLM": "Hayes PC, Plevris JN, Bouchier IA. Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function. J Hum Hypertens. 1989 Jun;3 Suppl 1():153-8. PMID: 2550638", "BibTeX": "@article{2550638, title={Pharmacokinetics of enalapril and lisinopril in subjects with normal and impaired hepatic function.}, author={Hayes PC and Plevris JN and Bouchier IA}, journal={J Hum Hypertens}, volume={3 Suppl 1}, pages={153-8}}"}}, {"_id": "30243070", "pmid": 30243070, "title": "Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis.", "journal": "Int Immunopharmacol", "authors": ["Saber S", "Goda R", "El-Tanbouly GS", "Ezzat D"], "date": "2018-11-01T00:00:00Z", "doi": "10.1016/j.intimp.2018.09.021", "meta_date_publication": "2018 Nov", "meta_volume": "64", "meta_issue": "", "meta_pages": "340-349", "score": 50066.957, "text_hl": "@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@Lisinopril@@@ inhibits nuclear transcription factor kappa B and augments sensitivity to @CHEMICAL_Silymarin @CHEMICAL_MESH:D012838 @@@silymarin@@@ in experimental @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver fibrosis@@@.", "citations": {"NLM": "Saber S, Goda R, El-Tanbouly GS, Ezzat D. Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis. Int Immunopharmacol. 2018 Nov;64():340-349. PMID: 30243070", "BibTeX": "@article{30243070, title={Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis.}, author={Saber S and Goda R and El-Tanbouly GS and Ezzat D}, journal={Int Immunopharmacol}, volume={64}, pages={340-349}}"}}, {"_id": "20201315", "pmid": 20201315, "title": "[Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis].", "journal": "Eksp Klin Gastroenterol", "authors": ["Fedulenkova LV"], "date": "2009-01-01T00:00:00Z", "meta_date_publication": "2009", "meta_volume": "", "meta_issue": "5", "meta_pages": "130-7", "score": 50063.19, "text_hl": "The tendency of the reduction of the functional index due to the expressed @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotensive@@@ effect of nebevolol and @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ was revealed in all examined @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@. ", "citations": {"NLM": "Fedulenkova LV. [Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis]. Eksp Klin Gastroenterol. 2009;(5):130-7. PMID: 20201315", "BibTeX": "@article{20201315, title={[Correction of portal hypertension and renal dysfunction with help of nebivolol and lizinopril in patients with hepatic cirrhosis].}, author={Fedulenkova LV}, journal={Eksp Klin Gastroenterol}, number={5}, pages={130-7}}"}}, {"_id": "29890165", "pmid": 29890165, "title": "The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.", "journal": "Exp Parasitol", "authors": ["Parreira NA", "Ramalho FS", "Augusto MJ", "Silva DM", "Prado CM", "Elias Júnior J", "Rodrigues V", "Ramalho LNZ"], "date": "2018-08-01T00:00:00Z", "doi": "10.1016/j.exppara.2018.05.004", "meta_date_publication": "2018 Aug", "meta_volume": "191", "meta_issue": "", "meta_pages": "9-18", "score": 50063.02, "text_hl": "The hepatic areas stained with Sirius red and thenumber of cells marked by @GENE_ACTA2 @GENE_11475 @@@alpha-SMA@@@ in animals treated with @CHEMICAL_aliskiren @CHEMICAL_MESH:C446481 @@@aliskiren@@@, bradykinin, @<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Losartan @CHEMICAL_MESH:D019808 @@@losartan@@@ were diminished when compared to control group, demonstrating reduced @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@hepatic fibrosis@@@ after RAS blockade. ", "citations": {"NLM": "Parreira NA, Ramalho FS, Augusto MJ, Silva DM, Prado CM, Elias Júnior J, Rodrigues V, Ramalho LNZ. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis. Exp Parasitol. 2018 Aug;191():9-18. PMID: 29890165", "BibTeX": "@article{29890165, title={The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.}, author={Parreira NA and Ramalho FS and Augusto MJ and Silva DM and Prado CM and Elias Júnior J and Rodrigues V and Ramalho LNZ}, journal={Exp Parasitol}, volume={191}, pages={9-18}}"}}, {"_id": "18389599", "pmid": 18389599, "title": "[Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].", "journal": "Eksp Klin Gastroenterol", "authors": ["Lazebnik LB", "Mikheeva OM", "Toporkov AS", "Komissarenko IA", "Vasnev OS", "Fedulenkova LV"], "date": "2007-01-01T00:00:00Z", "meta_date_publication": "2007", "meta_volume": "", "meta_issue": "5", "meta_pages": "57-66", "score": 50055.59, "text_hl": "[Correction of @DISEASE_Hypertension_Portal @DISEASE_MESH:D006975 @@@portal hypertension@@@ by beta-adrenoblockers (@CHEMICAL_Atenolol @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@) and inhibitors of @GENE_AP2B1 @GENE_163 @@@ACE@@@ (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@ and @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@) in @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@].", "citations": {"NLM": "Lazebnik LB, Mikheeva OM, Toporkov AS, Komissarenko IA, Vasnev OS, Fedulenkova LV. [Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis]. Eksp Klin Gastroenterol. 2007;(5):57-66. PMID: 18389599", "BibTeX": "@article{18389599, title={[Correction of portal hypertension by beta-adrenoblockers (atenolol and metoprolol) and inhibitors of ACE (lisinopril and enalapril) in liver cirrhosis].}, author={Lazebnik LB and Mikheeva OM and Toporkov AS and Komissarenko IA and Vasnev OS and Fedulenkova LV}, journal={Eksp Klin Gastroenterol}, number={5}, pages={57-66}}"}}, {"_id": "19257863", "pmid": 19257863, "title": "[Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors].", "journal": "Kardiologiia", "authors": ["Lazebnik LB", "Komissarenko IA", "Mikheeva OM", "Drozdov VN", "Sil'vestrova SIu", "Petrakov AV"], "date": "2009-01-01T00:00:00Z", "meta_date_publication": "2009", "meta_volume": "49", "meta_issue": "3", "meta_pages": "28-33", "score": 50054.82, "text_hl": "Hydrophilic angiotensin converting enzyme inhibitors (ACEI) (@<m>CHEMICAL_Lisinopril</m> @CHEMICAL_MESH:D017706 @@@lisinopril@@@) which are not metabolized in the @DISEASE_Liver_Failure @DISEASE_MESH:D017093 @@@liver@@@ are theoretically safest in @<m>DISEASE_Liver_Cirrhosis</m> @DISEASE_MESH:D008103 @@@liver cirrhosis@@@. ", "citations": {"NLM": "Lazebnik LB, Komissarenko IA, Mikheeva OM, Drozdov VN, Sil'vestrova SIu, Petrakov AV. [Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors]. Kardiologiia. 2009;49(3):28-33. PMID: 19257863", "BibTeX": "@article{19257863, title={[Combination therapy of arterial hypertension combined with liver pathology. The place of angiotensin converting enzyme inhibitors].}, author={Lazebnik LB and Komissarenko IA and Mikheeva OM and Drozdov VN and Sil'vestrova SIu and Petrakov AV}, journal={Kardiologiia}, volume={49}, number={3}, pages={28-33}}"}}]}